| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/24/2002 | WO2001022810A3 Transgenic animals expressing von willebrand factor (vwf) and vwf-related polypeptides |
| 01/24/2002 | WO2001019860A3 Proteins associated with cell differentiation |
| 01/24/2002 | WO2001019855A3 Pharmaceutical compositions and methods of using secreted frizzled related protein |
| 01/24/2002 | WO2001016181A3 Crystal structures of domains of receptor protein tyrosine kinases and their ligands |
| 01/24/2002 | WO2001014417A3 Pesticidal proteins |
| 01/24/2002 | WO2001012856A3 Analysis of sequence tags with hairpin primers |
| 01/24/2002 | WO2001012654A3 Orally active peptides that prevent cell damage and death |
| 01/24/2002 | WO2001008708A3 Enhanced delivery via serpin enzyme complex receptor ligands |
| 01/24/2002 | WO2001000787A3 Methods of treatment using lig 72a and variants thereof |
| 01/24/2002 | WO2001000655A3 Therapeutic peptides derived from subsequences of bpi |
| 01/24/2002 | WO2000073453A9 T-bet compositions and methods of use thereof |
| 01/24/2002 | WO2000073338A9 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer |
| 01/24/2002 | WO2000071574A3 Antigenic neisserial peptides |
| 01/24/2002 | US20020010950 Nucleotide sequences coding preferential polypeptide; for use as tool in genetic engineering |
| 01/24/2002 | US20020010947 Transgenic mouse model of human neurodegenerative disease |
| 01/24/2002 | US20020010945 Kelch family of proteins and use thereof |
| 01/24/2002 | US20020010944 CeSERT genes, proteins, and modulatory compounds |
| 01/24/2002 | US20020010325 Complexing; purified polypeptide |
| 01/24/2002 | US20020010324 Genetic engineering; polypeptides |
| 01/24/2002 | US20020010321 Truncated forms of NY-ESO-1 protein |
| 01/24/2002 | US20020010319 Separation of polypeptide monomers |
| 01/24/2002 | US20020010318 Enzyme inhibitor; for use in treatment of lung defects, asthma, bronchitis, emphysema and respiratory system disorders |
| 01/24/2002 | US20020010144 Inserting wild-type therapy-sensitizing gene activity into tumor cells having mutant therapy-sensitizing gene activity and subjecting the tumor cells to a cancer therapy |
| 01/24/2002 | US20020010137 Methods and compositions for inhibiting neoplastic cell growth |
| 01/24/2002 | US20020010136 Having an increased positive regulatory activity for expression of tyrosine phenol lyase gene, a gene coding for the same; biosynthesis of L-3,5-dihydroxyphenylalanine (L-DOPA) |
| 01/24/2002 | US20020010135 Having different amino acid sequence or chemically modified so the isoelectric point is lower to improve bioavailability relative the unmodified cationic polypeptide; DNA; expression vectors; transformed cells; treating neuropathies |
| 01/24/2002 | US20020010134 Peptide compositions mimicking tgf-beta activity |
| 01/24/2002 | US20020010129 Stabilizing a polypeptide by shock heat treatment; peptide drugs or prodrugs such as glucagon, insulin, glucagon-like peptide (GLP) GLP-1, GLP-2, human growth hormone, Factor VII, Factor VIIa, or Factor VIIai |
| 01/24/2002 | US20020009978 Units for displaying information on vehicles |
| 01/24/2002 | US20020009804 32705, 23224, 27423, 32700, 32712, novel human G-proteins |
| 01/24/2002 | US20020009802 Removing preferential microorganism from sample; obtain sample, incubate with prophylactic agent, monitor sample for presence of microorganism |
| 01/24/2002 | US20020009798 Ob protein compositions and methods |
| 01/24/2002 | US20020009792 Nucleotide sequences coding protein; for use in wastewater treatment |
| 01/24/2002 | US20020009786 Novel nucleic acids and polypeptides |
| 01/24/2002 | US20020009781 Methods for recombinant peptide production |
| 01/24/2002 | US20020009780 Design and discovery of protein based TNF-alpha variants for the treatment of TNF-alpha related disorders |
| 01/24/2002 | US20020009778 Thyroid and pituitary membrane protein |
| 01/24/2002 | US20020009776 Fibroblast growth factor receptor-like molecules and uses thereof |
| 01/24/2002 | US20020009775 Polypeptide for use in treatment of diabetes, anemias, hyperplasia, restenosis and periodontal disease; antitumor agents; wound healing agents; antiischemic agents |
| 01/24/2002 | US20020009773 Nucleotide sequences coding protein associated with apoptosis; for use in treatment of defects of apoptosis and inflammation |
| 01/24/2002 | US20020009772 Novel human calcium channels and related probes, cell lines and mehtods |
| 01/24/2002 | US20020009771 G protein coupled receptor proteins, their production and use |
| 01/24/2002 | US20020009758 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/24/2002 | US20020009756 Biosynthesis of amino acid sequences; assign value to peptides, rearrange peptides according to numerical value, graph values, synthesize preferential peptide |
| 01/24/2002 | US20020009755 Metastatic classification of tumors; obtain tumor biopsy, monitor expression of preferential receptor isoform, amplified quantities of preferential receptor isoform indicates potential for matastasis |
| 01/24/2002 | US20020009751 Nucleotide sequences coding protein for use in treatment and prevention of metabolic defects |
| 01/24/2002 | US20020009750 Monoclonal antibodies specific to vegf receptors and uses thereof |
| 01/24/2002 | US20020009749 Diagnostic drugs for autoimmune diseases |
| 01/24/2002 | US20020009745 Methods for detecting and classifying bladder cancer via human uroplakin genes |
| 01/24/2002 | US20020009739 Metastatic breast and colon cancer regulated genes |
| 01/24/2002 | US20020009726 CD40 associated proteins |
| 01/24/2002 | US20020009724 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 01/24/2002 | US20020009720 Plag gene family and tumorigenesis |
| 01/24/2002 | US20020009715 Detecting nucleotide sequences which code cell surface protease; incubate target cells with viral display packages and detect signal from transformed cells |
| 01/24/2002 | US20020009465 Vaccines |
| 01/24/2002 | US20020009462 Herpesvirus replication defective mutants |
| 01/24/2002 | US20020009459 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 01/24/2002 | US20020009458 DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same |
| 01/24/2002 | US20020009455 Prostate glands; diagnosis, therapy |
| 01/24/2002 | US20020009454 Composition and method for treating inflammatory diseases |
| 01/24/2002 | US20020009452 Method for altering undesirable immune responses to polypeptides |
| 01/24/2002 | US20020009449 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction |
| 01/24/2002 | US20020009446 Method of modulating memory effector T-cells and compositions |
| 01/24/2002 | US20020009443 Binding to platelet-devived growth factor |
| 01/24/2002 | US20020009441 Administering mixture of binding agent and active materials |
| 01/24/2002 | US20020009439 Central nervous system disorders therapy; genetic engineered culture; Alzheimer's disease |
| 01/24/2002 | US20020009432 Promoter for chondrocyte proliferation agent; administering hepatocyte growth factor |
| 01/24/2002 | DE10126344A1 Apoptose-induzierende DNA-Sequenzen Apoptosis-inducing DNA sequences |
| 01/24/2002 | DE10033353A1 Identifying compounds that modify activity of signal transduction pathways, useful potentially as therapeutic agents, by screening with cells that contain hybrid G proteins |
| 01/24/2002 | DE10030466A1 Nukleotid- und Aminosäurensequenzen eines zellulären Repressors der DNA Replikation des Herpesvirus Epstein-Barr Nucleotide and amino acid sequences of a cellular repressor of DNA replication of the herpes virus Epstein-Barr |
| 01/24/2002 | CA2697031A1 Detection and treatment of polycystic kidney disease |
| 01/24/2002 | CA2419156A1 Multimeric biopolymers as structural elements, sensors and actuators in microsystems |
| 01/24/2002 | CA2418391A1 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 01/24/2002 | CA2418207A1 Dendritic cell-derived nucleic acids and related compositions and methods |
| 01/24/2002 | CA2417789A1 Peptides and their use in assays for cardiovascular disease |
| 01/24/2002 | CA2416813A1 Mutated pf-4, its fragments and mutated fusion peptides, their analogues, corresponding dna, cdna and mrna sequences and their use for inhibiting angiogenesis |
| 01/24/2002 | CA2416693A1 Phosphatonin-related gene and methods of use thereof |
| 01/24/2002 | CA2416452A1 Novel proteins and nucleic acids encoding same |
| 01/24/2002 | CA2416445A1 Human rrp sequences and methods of use |
| 01/24/2002 | CA2416153A1 Mutant rad51 paralog genes and use thereof in anticancer therapy |
| 01/24/2002 | CA2415938A1 Alpha-msh related compounds and methods of use |
| 01/24/2002 | CA2415751A1 Masp-2, a complement-fixing enzyme, and uses for it |
| 01/24/2002 | CA2415726A1 Regulation of gene expression using single-chain, monomeric, ligand dependent polypeptide switches |
| 01/24/2002 | CA2415712A1 Protein complex serving as a vehicle for orally administerable medicaments |
| 01/24/2002 | CA2415690A1 Tetraspan protein and uses thereof |
| 01/24/2002 | CA2415687A1 Novel g-protein coupled receptor |
| 01/24/2002 | CA2415481A1 Antifungal and/or antibacterial peptides, preparation methods and composition containing same |
| 01/24/2002 | CA2415327A1 Zmaxig1 polynucleotides and methods of use |
| 01/24/2002 | CA2415232A1 Lipoxygenase genes, promoters, transit peptides and proteins thereof |
| 01/24/2002 | CA2415202A1 Extracellular matrix protein |
| 01/24/2002 | CA2415187A1 Dna vaccines encoding hiv accessory proteins |
| 01/24/2002 | CA2410898A1 Substrates and assays for .beta.-secretase activity |
| 01/24/2002 | CA2351788A1 A method for detecting psa and its molecular forms using thiophilic gel |
| 01/23/2002 | EP1174516A1 Fractionation of soybean 7s globulin and 11s globulin and process for producing the same |
| 01/23/2002 | EP1174514A1 Recombinant influenza viruses with bicistronic vRNAs coding for two genes in tandem arrangement |
| 01/23/2002 | EP1174507A1 The full gene sequence of the donkey leukocyte vaccine strain of the equine infectious anemia virus and their application |
| 01/23/2002 | EP1174506A1 C-terminal Erns peptide and analogues thereof |
| 01/23/2002 | EP1174505A1 (Poly)peptides for the preparation of vaccines against Bordetella pertussis and/or Bordetella parapertussis, vaccines based upon such (poly)peptides, and antibodies against such peptides |
| 01/23/2002 | EP1174504A1 Apoptosis-associated gene |
| 01/23/2002 | EP1174503A1 Novel proteins, gene encoding the same and method of utilization thereof |